XOMA Royalty (XOMA) Total Debt (QoQ) (2011 - 2026)
XOMA Royalty (XOMA) Total Debt (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.63% |
| Jun 30, 2025 | 0.21% |
| Mar 31, 2025 | -3.92% |
| Dec 31, 2024 | 0.30% |
| Sep 30, 2024 | -2.38% |
| Jun 30, 2024 | 0.10% |
| Mar 31, 2024 | -2.73% |
| Mar 31, 2021 | -9.58% |
| Dec 31, 2020 | -30.38% |
| Sep 30, 2020 | -3.67% |
| Jun 30, 2020 | -1.39% |
| Mar 31, 2020 | -2.31% |
| Dec 31, 2019 | -1.23% |
| Sep 30, 2019 | 25.58% |
| Jun 30, 2019 | 15.23% |
| Mar 31, 2019 | 0.46% |
| Dec 31, 2018 | 2.02% |
| Sep 30, 2018 | 48.35% |
| Jun 30, 2018 | 1.93% |
| Mar 31, 2018 | 0.00% |